Dynavax Technologies Corp (DVAX)
12.59
+0.17
(+1.37%)
USD |
NASDAQ |
Nov 25, 14:12
Dynavax Technologies Revenue (Quarterly): 80.63M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 80.63M |
| June 30, 2024 | 73.80M |
| March 31, 2024 | 50.79M |
| December 31, 2023 | 55.60M |
| September 30, 2023 | 69.51M |
| June 30, 2023 | 60.25M |
| March 31, 2023 | 46.92M |
| December 31, 2022 | 184.49M |
| September 30, 2022 | 167.74M |
| June 30, 2022 | 256.46M |
| March 31, 2022 | 113.99M |
| December 31, 2021 | 195.07M |
| September 30, 2021 | 108.27M |
| June 30, 2021 | 52.77M |
| March 31, 2021 | 83.34M |
| December 31, 2020 | 19.55M |
| September 30, 2020 | 13.41M |
| June 30, 2020 | 2.668M |
| March 31, 2020 | 10.92M |
| December 31, 2019 | 10.57M |
| September 30, 2019 | 10.58M |
| June 30, 2019 | 8.301M |
| March 31, 2019 | 5.773M |
| December 31, 2018 | 5.318M |
| September 30, 2018 | 1.461M |
| Date | Value |
|---|---|
| June 30, 2018 | 1.254M |
| March 31, 2018 | 0.165M |
| December 31, 2017 | 0.021M |
| September 30, 2017 | 0.053M |
| June 30, 2017 | 0.105M |
| March 31, 2017 | 0.148M |
| December 31, 2016 | 7.292M |
| September 30, 2016 | 0.162M |
| June 30, 2016 | 2.647M |
| March 31, 2016 | 0.942M |
| December 31, 2015 | 0.685M |
| September 30, 2015 | 1.188M |
| June 30, 2015 | 1.55M |
| March 31, 2015 | 0.627M |
| December 31, 2014 | 2.277M |
| September 30, 2014 | 2.209M |
| June 30, 2014 | 3.048M |
| March 31, 2014 | 3.498M |
| December 31, 2013 | -2.291M |
| September 30, 2013 | 2.927M |
| June 30, 2013 | 3.392M |
| March 31, 2013 | 2.085M |
| December 31, 2012 | -2.133M |
| September 30, 2012 | 2.874M |
| June 30, 2012 | 2.684M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.668M
Minimum
Jun 2020
256.46M
Maximum
Jun 2022
82.84M
Average
64.88M
Median
Revenue (Quarterly) Benchmarks
| Biogen Inc | 2.466B |
| Repligen Corp | 154.87M |
| West Pharmaceutical Services Inc | 746.90M |
| Janux Therapeutics Inc | 0.439M |
| XOMA Royalty Corp | 0.734M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.59M |
| Total Expenses (Quarterly) | 70.55M |
| EPS Diluted (Quarterly) | 0.12 |
| Enterprise Value | 1.092B |
| Gross Profit Margin (Quarterly) | 83.77% |
| Profit Margin (Quarterly) | 21.82% |
| Earnings Yield | 1.03% |
| Normalized Earnings Yield | 1.033 |